These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32839459)

  • 21. Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding.
    Shi J; Anderson D; Lynch BA; Castaigne JG; Foerch P; Lebon F
    Biochem Soc Trans; 2011 Oct; 39(5):1341-7. PubMed ID: 21936812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.
    Vogl C; Tanifuji S; Danis B; Daniels V; Foerch P; Wolff C; Whalley BJ; Mochida S; Stephens GJ
    Eur J Neurosci; 2015 Feb; 41(4):398-409. PubMed ID: 25484265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.
    Löscher W; Gillard M; Sands ZA; Kaminski RM; Klitgaard H
    CNS Drugs; 2016 Nov; 30(11):1055-1077. PubMed ID: 27752944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats.
    Wang L; Shi J; Wu G; Zhou F; Hong Z
    Epilepsy Res; 2014 Nov; 108(9):1483-91. PubMed ID: 25205164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.
    Janz R; Südhof TC
    Neuroscience; 1999; 94(4):1279-90. PubMed ID: 10625067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events.
    Romoli M; Mandarano M; Romozzi M; Eusebi P; Bedetti C; Nardi Cesarini E; Verzina A; Calvello C; Loreti E; Sidoni A; Giovenali P; Calabresi P; Costa C
    J Neurol; 2019 Sep; 266(9):2273-2276. PubMed ID: 31168673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
    Vanoye-Carlo A; Gómez-Lira G
    Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide analysis of miRNA and mRNA transcriptomes during amelogenesis.
    Yin K; Hacia JG; Zhong Z; Paine ML
    BMC Genomics; 2014 Nov; 15(1):998. PubMed ID: 25406666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    Stockburger C; Miano D; Baeumlisberger M; Pallas T; Arrey TN; Karas M; Friedland K; Müller WE
    J Alzheimers Dis; 2016; 50(1):201-15. PubMed ID: 26639968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants.
    Badura-Stronka M; Kuszel Ł; Wencel-Warot A; Cudnoch K; Wołyńska K; Rutkowska K; Steinborn B; Płoski R
    Epilepsy Res; 2023 Feb; 190():107101. PubMed ID: 36758444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein.
    Wood MD; Sands ZA; Vandenplas C; Gillard M
    Epilepsia; 2018 Sep; 59(9):e147-e151. PubMed ID: 30144048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pinpointing miRNA and genes enrichment over trait-relevant tissue network in Genome-Wide Association Studies.
    Li B; Dong J; Yu J; Fan Y; Shang L; Zhou X; Bai Y
    BMC Med Genomics; 2020 Dec; 13(Suppl 11):191. PubMed ID: 33371893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.
    Itesako T; Seki N; Yoshino H; Chiyomaru T; Yamasaki T; Hidaka H; Yonezawa T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    PLoS One; 2014; 9(2):e84311. PubMed ID: 24520312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
    Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
    J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA
    Wood M; Daniels V; Provins L; Wolff C; Kaminski RM; Gillard M
    J Pharmacol Exp Ther; 2020 Jan; 372(1):1-10. PubMed ID: 31619465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human synaptic vesicle protein, SV2A, functions as a galactose transporter in Saccharomyces cerevisiae.
    Madeo M; Kovács AD; Pearce DA
    J Biol Chem; 2014 Nov; 289(48):33066-71. PubMed ID: 25326386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
    J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
    Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
    Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.